CSB 2.012 Note CSB 2.47 Addition of AH-7921 to schedule I. Section 961.14 (2) (aj), Stats., is created to read:

CSB 2.012 Note 961.14 (2) (aj) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide).

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register November 2016 No. 731, eff. 11-21-16; CR 17-023: cr. Register November 2017 No. 743, eff. 12-1-17.

CSB 2.012 Note CSB 2.48 Addition of eluxadoline to schedule IV. Section 961.20 (4) (cm), Stats., is created to read:

CSB 2.012 Note 961.20 (4) (cm) Eluxadoline, including any of its isomers, and salts of isomers.

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register November 2016 No. 731, eff. 11-21-16; CR 17-022: cr. Register November 2017 No. 743, eff. 12-1-17.

CSB 2.012 Note CSB 2.49 Addition of U-47700 to schedule I. Section 961.14 (2) (z), Stats., is created to read:

CSB 2.012 Note 961.14 (2) (z) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide).

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register December 2016 No. 732, eff. 12-19-16; CR 17-020: cr. Register November 2017 No. 743, eff. 12-1-17.

CSB 2.012 Note CSB 2.50 Addition of AB-CHMINACA, AB-PINACA and THJ-2201 to schedule I. Section 961.14 (4) (tb) 34., 35., and 36., Stats., are created to read:

CSB 2.012 Note 961.14 (4) (tb) 34. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as AB-CHMINACA.

CSB 2.012 Note 35. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, commonly known as AB-PINACA).

CSB 2.012 Note 36. [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, commonly known as THJ-2201.

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2017 No. 736, eff. 3-27-17; correction in (intro.) made under s. 35.17, Stats., Register April 2017 No. 736; CR 17-085: cr. Register October 2018 No. 754, eff. 11-1-18; correction in (intro.) made under s. 35.17, Stats., Register October 2018 No. 754.

CSB 2.012 Note CSB 2.51 Addition of MAB-CHMINACA to schedule I. Section 961.14 (4) (tb) 37., Stats., is created to read:

CSB 2.012 Note 961.14 (4) (tb) 37. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as MAB-CHMINACA or ADB-CHMINACA.

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2017 No. 736, eff. 3-27-17; CR 17-086: cr. Register October 2018 No. 754, eff. 11-1-18.

CSB 2.012 Note CSB 2.52 Addition of 4-MePPP and a-PBP to schedule I. Section 961.14 (7) (L) 32. and 33., Stats., is created to read:

CSB 2.012 Note 961.14 (7) (L) 32. 4-methyl-alpha-pyrrolidinopropiophenone, commonly known as 4-MePPP.

CSB 2.012 Note 33. Alpha-pyrrolidinobutiophenone, commonly known as a-PBP.

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2017 No. 736, eff. 4-10-17; CR 17-087: cr. Register October 2018 No. 754, eff. 11-1-18.

CSB 2.012 Note CSB 2.53 Scheduling of acryl fentanyl. Section 961.14 (2) (ai), Stats., is created to read:

CSB 2.012 Note 961.14 (2) (ai) Acryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2-propenamide);

CSB 2.012 Note Section 961.14 (2) (ai), Stats., was renumbered to s. 961.14 (2) (nd) 3. by 2017 Wis. Act 60.

CSB 2.012 History History: EmR1710: emerg. cr., eff. 5-2-17; CR 17-040: cr. Register November 2017 No. 743, eff. 12-1-17; correction made under s. 35.17, Stats., Register November 2017 No. 743.

CSB 2.012 Note CSB 2.54 Addition of oral solutions containing dronabinol to schedule II. Section 961.16 (10), Stats., is created to read:

CSB 2.012 Note 961.16 (10) (a) Dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] in an oral solution in a drug product approved by the U.S. food and drug administration.

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register May 2017 No. 737, eff. 5-15-17; CR 18-055: cr. Register June 2019 No. 762, eff. 7-1-19.

CSB 2.012 Note CSB 2.55 Addition of 5F-ADB, 5F-AMB, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA to schedule I. Section 961.14 (4) (tb) 38., 39., 40., 41., and 42., Stats., is created to read: